MEDIK8 SKINCARE BRAND RECEIVES INVESTMENT FROM INFLEXION LONDON. Inflexion is pleased to announce that it has completed an investment in Pangaea Laboratories (“Pangaea”), a global beauty business and owner of the fast-growing Medik8 skincare brand. The investment is being made by Inflexion Buyout Fund V, Inflexion’s dedicated mid-market fund. Founder-led since 1999, Pangaea is an innovative and fully vertically integrated firm with two facilities in Hertfordshire, where Medik8’s products are developed and manufactured in-house. Medik8 is a premium British skincare brand focused on science-based, skin-ageing products centered around their trademark ‘CSA Philosophy’. With a strong heritage in the international professional channel and a growing online presence, Medik8 is committed to ethical manufacturing and sustainability. Medik8 is focused on enhancing its strong relationships within the professional beauty industry while growing digital channels in new international markets. Elliot Isaacs, Founder of Medik8, commented, “In the last three years, the brand has experienced phenomenal growth as the skincare consumer has become more knowledgeable and moved towards science and ingredients. We are thrilled to be partnering with Inflexion who have the passion and expertise to help us accelerate the brand’s international ambitions. Crucially, Inflexion have been unwavering in their support for our amazing team and professional-led heritage. We could not be more excited about the future.” Simon Turner, Managing Partner of Inflexion, commented, “Medik8’s science-based approach to skincare combined with its sustainability credentials make it an incredibly impressive business. We look forward to working closely with the whole team to scale the business further through enhancing their digital routes to market, and by supporting their continued innovation, new product launches and international expansion.” For further information, please contact: Julia Kendrick 07890 711 037 Email: julia@kendrickpr.uk
About Medik8 With the ultimate mission of ‘Beautiful Skin for Life’, Medik8 has successfully disrupted the conversation about skincare and empowered consumers with simplicity - putting science centre-stage. The secret is, there is no secret! Starting with dermatologists, skincare experts and die-hard enthusiasts, their ‘CSA Philosophy’ comprising the idea of vitamin C plus
Sunscreen in the day, with vitamin A at night has rapidly spread to the wider audience of premium skincare buyers who seek a rational, ethical and high quality product offering. Medik8 is recognised as a market leader in vitamin A skincare technologies which are considered by those ‘in-the-know’ as the gold-standard. The freedom to ignore the cyclical beauty trends and instead be focused on perfecting just three ingredients as their core technology offering has allowed Medik8 to catapult itself into a position of authority in this highly fragmented market and also gained them a loyal social media following. With a whole raft of accessory products and a large professional network offering treatments, Medik8 has set its own path grounded in truth and also delivered the hygiene factors required in this consumer space of stylish yet sustainable packaging plus ethical sourcing. For more information, visit www.medik8.com About Inflexion Inflexion is a mid-market private equity firm which invests in high growth, entrepreneurial businesses and works in partnership with their ambitious management teams to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £300m of equity in each deal. With bespoke teams and dedicated capital, Inflexion’s funds invest across a variety of sectors from offices in London, Manchester and Amsterdam as well as Bangalore, Boston, Sao Paulo and Shanghai. Inflexion helps businesses achieve the next stage of their development through M&A, international expansion, digital enhancement, talent management, commercial strategy, and access to the Inflexion network. In 2020 Inflexion retained a leading position in Preqin’s annual global league table for consistently top performing buyout funds. It is the only UK fund to be ranked in the top 10. Inflexion has also won a number of industry accolades for its success in growing the businesses it backs. Funds advised by Inflexion Private Equity Partners LLP have approximately £5.4bn under management. Read more at www.inflexion.com
